Patent Assignment
Reel/Frame 065120/0663
Change of Name
Recorded: 2023-10-04
Pages: 5
Assignor
AI THERAPEUTICS, INC.
Executed: 2023-09-21
Assignee
ORPHAI THERAPEUTICS INC.
530 OLD WHITFIELD STREET, GUILFORD, CONNECTICUT, 06437
Covered Properties
(33)
Aureolic Acid Derivatives, the Method for Preparation Thereof and the Uses Thereof
Rapamycin for the Treatment of Lymphangioleiomyomatosis
Apilimod Compositions and Methods for Using Same
Apilimod for Use in the Treatment of Melanoma
Apilimod for Use in the Treatment of Renal Cancer
Anti-Viral Compositions Containing Pikfyve Inhibitors and Use Thereof
Active Metabolites of Apilimod and Uses Thereof
Application:
15/563,115 →
Publication:
US 2018/0078561
Combinations of a Mithramycin Analogue and Another Chemotherapeutic Agent for the Treatment of Triple Negative Breast Cancer
Rapamycin for the Treatment of Lymphangioleiomyomatosis
Methods for treating cancer using HSP90 inhibitors
Compositions and Methods Relating to the Radioprotective Effects of Apilimod
An Inhalable Rapamycin Formulation for Treating Age-Related Conditions
Combination Therapy with Apilimod and Glutamatergic Agents
Apilimod Compositions and Methods for Using Same in the Treatment of Alzheimer's Disease
Application:
16/340,845 →
Publication:
US 2019/0365771
Apilimod Compositions and Methods for Using Same in the Treatment of Renal Cancer
Rapamycin for the Treatment of Lymphangioleiomyomatosis
Apilimod Compositions and Methods for Using Same
Inhalable Rapamycin Formulation for the Treatment of Pulmonary Hypertension
Compositions and Methods for Treating Niemann Pick C Disease
Application:
16/782,614 →
Publication:
US 2020/0306255
Combination Therapy with Apilimod and Glutamatergic Agents
Anti-Viral Compositions and Methods of Use
Application:
17/248,696 →
Publication:
US 2021/0244743
Inhalable Rapamycin Formulation for Treating Age-Related Conditions
Rapamycin for the Treatment of Lymphangioleiomyomatosis
Combination Therapy with Apilimod and Glutamatergic Agents
Inhalable Rapamycin Formulation for the Treatment of Pulmonary Hypertension
Application:
17/965,859 →
Publication:
US 2023/0255944
Inhalable Rapamycin Formulation for Treating Age-Related Conditions
Application:
18/132,743 →
Publication:
US 2023/0240986
Rapamycin for the Treatment of Lymphangioleiomyomatosis
Antiviral Compositions and Methods
Application:
18/281,942 →
Publication:
US 2024/0189317
Apilimod Combination Therapy
Application:
63/425,430 →
Apilimod Combination Therapy
Application:
63/425,434 →
Apilimod Combination Therapy
Application:
63/425,441 →
Pikfyve Inhibitor Combination Therapy
Application:
63/428,365 →
Pikfyve Inhibitor Combination Therapy
Application:
63/452,381 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 19, 2012
From: NUNEZ GONZALEZ, LUZ ELENA; MENENDEZ SANCHEZ, NURIA; GONZALEZ SABIN, JAVIER; MORIS VARAS, FRANCISCO
To: ENTRECHEM, S.L.
Reel/Frame 028076/0001 →
Assignment of Assignor's Interest
Mar 10, 2017
From: LICHENSTEIN, HENRI; ROTHBERG, JONATHAN M.; ARMER, THOMAS; MELVIN, LAWRENCE S., JR.
To: LAM THERAPEUTICS, INC.
Reel/Frame 041538/0907 →
Assignment of Assignor's Interest
Jul 21, 2017
From: LICHENSTEIN, HENRI; ROTHBERG, JONATHAN M.; BEEHARRY, NEIL; BECKETT, PAUL
To: LAM THERAPEUTICS, INC.
Reel/Frame 043060/0064 →
Assignment of Assignor's Interest
Sep 29, 2017
From: BECKETT, PAUL; BEEHARRY, NEIL; LANDRETTE, SEAN; CONRAD, CHRIS
To: LAM THERAPEUTICS, INC.
Reel/Frame 043740/0649 →
Assignment of Assignor's Interest
Mar 28, 2018
From: LANDRETTE, SEAN; XU, TIAN; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 045374/0608 →
Assignment of Assignor's Interest
Aug 3, 2018
From: PANDIELLA ALONSO, ATANASIO; OCAÑA FERNANDEZ, ALBERTO; MORÍS VARAS, FRANCISCO
To: ENTRECHEM, S.L.
Reel/Frame 046712/0076 →
Assignment of Assignor's Interest
Sep 10, 2018
From: BEEHARRY, NEIL; GAYLE, SOPHIA; LANDRETTE, SEAN; BECKETT, PAUL
To: LAM THERAPEUTICS, INC.
Reel/Frame 046826/0242 →
Assignment of Assignor's Interest
Sep 10, 2018
From: BEEHARRY, NEIL; HERNANDEZ, MARYLENS; LANDRETTE, SEAN; XU, TIAN
To: LAM THERAPEUTICS, INC.
Reel/Frame 046824/0313 →
Assignment of Assignor's Interest
Sep 10, 2018
From: ARMER, THOMAS; MELVIN, LAWRENCE S., JR.; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 046824/0124 →
Assignment of Assignor's Interest
Sep 10, 2018
From: BEEHARRY, NEIL; GAYLE, SOPHIA; LANDRETTE, SEAN; BECKETT, PAUL
To: LAM THERAPEUTICS, INC.
Reel/Frame 046826/0313 →
Assignment of Assignor's Interest
Sep 14, 2018
From: ARMER, THOMAS; MELVIN, LAWRENCE S., JR.; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 046876/0517 →
Assignment of Assignor's Interest
Sep 27, 2018
From: LICHENSTEIN, HENRI; ROTHBERG, JONATHAN M.; GAYLE, SOPHIA; BEEHARRY, NEIL
To: LAM THERAPEUTICS, INC.
Reel/Frame 046993/0660 →
Assignment of Assignor's Interest
Oct 4, 2018
From: BEEHARRY, NEIL; GAYLE, SOPHIA; LANDRETTE, SEAN; BECKETT, PAUL
To: LAM THERAPEUTICS, INC.
Reel/Frame 047069/0440 →
Change of Name
Feb 26, 2019
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 048446/0249 →
Assignment of Assignor's Interest
Apr 4, 2019
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 048805/0306 →
Assignment of Assignor's Interest
Apr 10, 2019
From: LICHENSTEIN, HENRI; ROTHBERG, JONATHAN M.; CONRAD, CHRIS; HERNANDEZ, MARYLENS
To: LAM THERAPEUTICS, INC.
Reel/Frame 048847/0627 →
Change of Name
Apr 10, 2019
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 048852/0881 →
Change of Name
May 8, 2019
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 050924/0673 →
Assignment of Assignor's Interest
Mar 3, 2020
From: BEEHARRY, NEIL; GAYLE, SOPHIA; LANDRETTE, SEAN; BECKETT, PAUL
To: AI THERAPEUTICS, INC.
Reel/Frame 051997/0630 →
Change of Name
May 4, 2020
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 052562/0051 →
Assignment of Assignor's Interest
Jun 30, 2020
From: LICHENSTEIN, HENRI; LANDRETTE, SEAN; YOUNG, PETER R.; ROTHBERG, JONATHAN M.
To: AI THERAPEUTICS, INC.
Reel/Frame 053090/0288 →
Change of Name
Mar 11, 2021
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 055560/0865 →
Change of Name
Jul 27, 2021
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 056985/0916 →
Assignment of Assignor's Interest
Jul 27, 2021
From: BEEHARRY, NEIL; GAYLE, SOPHIA; LANDRETTE, SEAN; BECKETT, PAUL
To: LAM THERAPEUTICS, INC.
Reel/Frame 056982/0823 →
Change of Name
Jan 18, 2022
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 058926/0467 →